drugset / Trial / NCT01702181
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to investigate the pharmacokinetics and safety of OPA-15406 in adult subjects with atopic dermatitis
Timeline
- Start
- 2012-08
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Difamilast | Small molecule | 0.3 % | Topical |
| Subject | Difamilast | Small molecule | 1 % | Topical |
| Subject | Difamilast | Small molecule | 3 % | Topical |
| Comparator | Tacrolimus | Small molecule | 0.1 % | Topical |